Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2017-10-16 Board/Management Inform…
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Syncona Limited - Directorate Change
Board/Management Information Classification · 99% confidence The document explicitly announces a change in the company's leadership structure: 'Syncona appoints Robert Hutchinson as Non-Executive Director'. This content directly relates to the composition of the board of directors and senior management. This aligns perfectly with the definition for Board/Management Information (MANG). The document is short and focused solely on this announcement, not a comprehensive report.
2017-10-16 English
Syncona Limited - Directors Dealings
Director's Dealing Classification · 100% confidence The document explicitly states the title as 'Syncona Limited - Directors Dealings' and contains detailed information regarding the 'Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Connected Persons'. It lists the name of the associated person (Farla Limited, connected to a Non-Executive Director), the nature of the transaction ('Disposal of shares'), the volume, and the date. This content directly matches the definition for Director's Dealing reports.
2017-10-12 English
Syncona Limited - Nightstar announces closing of IPO
Share Issue/Capital Change Classification · 99% confidence The document is a press release from Syncona Limited announcing that its portfolio company, Nightstar Therapeutics, has closed its Initial Public Offering (IPO) in the United States. This announcement details a significant financing/capital event (the IPO closing and the resulting stake valuation for Syncona). This fits best under the 'Capital/Financing Update' category, as it directly relates to the capital structure and fundraising activities of a portfolio company, which is material information for Syncona's investors. It is not a full 10-K, an earnings release (ER), or a general regulatory filing (RNS), but a specific announcement about capital raising.
2017-10-03 English
Syncona Limited - Monthly Factsheet - August 2017
Fund Information / Factsheet Classification · 98% confidence The document is extremely short (972 characters) and explicitly states, 'Attached is a link to the August 2017 Monthly Fact Sheet for BACIT Limited.' It is titled 'Syncona Limited - Monthly Factsheet - August 2017'. This structure—a brief announcement pointing to an attached document—fits the definition of a Report Publication Announcement (RPA) or, given the content is a 'Factsheet', potentially Fund Information (FS). Since the primary action is announcing the publication of the factsheet, RPA is a strong candidate. However, the content *is* the factsheet summary itself, which aligns perfectly with the definition of 'Fund Information / Factsheet' (FS): 'Brief (1-2 page) summary of key company facts, financials, and market info.' The linked PDF is the factsheet. Given the explicit title 'Monthly Factsheet', FS is the most precise classification over the general RPA.
2017-09-29 English
Syncona Limited - Net Asset Value(s)
Net Asset Value Classification · 99% confidence The document explicitly states 'Syncona Limited - Net Asset Value(s)' in the title. It provides a table detailing the NAV as at August 31st, 2017, along with Total Return metrics. This content directly corresponds to the definition of Net Asset Value updates, which maps to the filing code NAV.
2017-09-29 English
Syncona Limited - Nightstar lists on NASDAQ
Share Issue/Capital Change Classification · 99% confidence The document is a press release announcing that Syncona Limited's portfolio company, Nightstar Therapeutics, has priced its Initial Public Offering (IPO) and begun trading on NASDAQ. This announcement details financing activities, investment stakes, and the resulting change in Syncona's asset allocation. This clearly falls under the category of updates related to company fundraising, financing activities, or capital structure changes, which aligns with the 'Capital/Financing Update' definition (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate finance event.
2017-09-28 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.